EN
HI
Glenmark Pharmaceuticals share price chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
2.58 L
Market Cap
63531.87 CR
LTQ@LTP
10@2251.30
ATP
2272.82
Var Margin
15.18 %
Circuit Range
2026.2-2476.4
Delivery %
36.37 %
Value
58.59 CR
ASM/GSM
No
Market Lot
1
Summary
GLENMARK stock price is ₹2251.3 as of 11 Aug, 2026. The stock intraday movement has stayed between ₹2251.30 and ₹2297.80, while Glenmark Pharmaceuticals share price 52 week high low is ₹1792.60 & ₹2474.00.
In terms of trading activity, GLENMARK share price has recorded a volume of 2,57,787 shares. The Glenmark Pharmaceuticals has a market cap of ₹282200809. The stock’s Average Traded Price (ATP) stands at ₹2272.82, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹2251.30.
The Glenmark Pharmaceuticals upper circuit limit is ₹2476.40 & The Glenmark Pharmaceuticals lower circuit limit is ₹2026.20, with a Value of ₹58.59 CR. The Delivery Percentage for the day is 36.37%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
36.04
P/B Ratio
5.89
Div. Yield
0.11
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Glenmark Pharmaceuticals Resistance and Support
Pivot 2266.8
Resistance
First Resistance
2282.3
Second Resistance
2313.3
Third Resistance
2328.8
Support
First Support
2235.8
Second Support
2220.3
Third Support
2189.3
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
25AUG26
2265.10
-2.90 (0.13%)
29SEP26
2275.40
-2.30 (0.10%)
27OCT26
2288.40
0.00 (0.00%)
GLENMARK|25AUG26 CE 2240.00
65.00
-0.6 (-0.91%)
GLENMARK|25AUG26 PE 2260.00
45.6
-0.15 (-0.33%)
Glenmark Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 10 2026 | 2293 | 2251.3 | -1.22% | 2297.8 | 2251.3 |
| Fri Aug 07 2026 | 2274.89 | 2279.1 | 0.40% | 2289 | 2256 |
| Thu Aug 06 2026 | 2270 | 2270 | 0.49% | 2290 | 2247 |
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Glenmark Pharmaceuticals will engage with analysts and institutional investors through a series of meetings in August and September 2026, including Emkay Confluence and Motilal Oswal's conference. The company clarified that no Unpublished Price Sensitive Information will be shared during these interactions.
Aug 07 2026 14:52:08
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Glenmark Pharmaceuticals has made the audio recording of its Q1 FY27 earnings call, held on August 03, 2026, available on its company website. This allows investors to review the discussion on the quarter's financial performance.
Aug 03 2026 16:30:40
Read More
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Manipal Health Enterprises Ltd.
686.35
0.00 (0.00%)
Aster DM Quality Care Ltd.
867.15
0.00 (0.00%)
Fortis Healthcare Ltd.
945.15
0.00 (0.00%)
Biocon Ltd.
426.10
0.00 (0.00%)
Alkem Laboratories Ltd.
5598.50
0.00 (0.00%)
Abbott India Ltd.
27535.00
0.00 (0.00%)
Anthem Biosciences Ltd.
853.00
0.00 (0.00%)
Ipca Laboratories Ltd.
1685.80
0.00 (0.00%)
Glaxosmithkline Pharmaceuticals Ltd.
2601.00
0.00 (0.00%)
Ajanta Pharma Ltd.
3506.20
0.00 (0.00%)
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2251.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 36.04. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 5.89. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 63531.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2474.00 & 1792.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
